Project title
Researcher(s)
Development of EphA2-Targeted Molecular Radiotheranostics for Lung Neuroendocrine Tumors
Ajay Kumar Sharma, PhD
Modeling to predict benefit of PRRT in NET patients
Victor Santoro Fernandes, PhD
Molecular mechanisms in the progression of pancreatic neuroendocrine tumors
Nancy Joseph, MD, PhD
Generation and characterization of a novel genetically modified patient–derived NET organoid system
James Yao, MD
Development of a Low Molecular Weight Fluorine-18 FAPI Imaging Agent and Companion Radiotherapeutic
Benjamin Viglianti, MD, PhD
Establishing & characterizing a pancreatic neuroendocrine tumor mouse model with humanized telomeres
Daniel Schramek, PhD
Deciphering novel neoantigen landscape and vaccine targets in pancreatic neuroendocrine neoplasms
Anguraj Sadanandam, PhD
Developing a functional in vitro model to investigate renal toxicity of radionuclide therapy agents
Susanne Kossatz, PhD
Glycomic characterization of pancreatic neuroendocrine neoplasms
Sharon Gorski, PhD
Harnessing ferroptosis initiating drugs to target GEP-NETs
Jeffrey Frost, PhD